Posted on 2/4/21
BrainStorm Announces Full Year 2020 Financial Results and Provides a Corporate Update
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the fiscal year ended December 31, . . .
Posted on 2/4/21
TYME Provides Business Update and Announces Third Quarter Fiscal 2021 Financial and Operating Results
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced financial and operating results for its third quarter ended . . .
Posted on 2/4/21
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2020
NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today reports results for the fourth quarter and full year of 2020, which reflect robust sales, strong operating performance and advancement . . .
Posted on 2/4/21
Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of . . .
Posted on 2/4/21
Bristol Myers Squibb Tender Offers for Price of Up to $4.0 Billion
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY), with its wholly-owned subsidiary Celgene Corporation, announced the commencement of 20 separate offers to purchase for cash notes issued by . . .
Posted on 2/4/21
TYME Announces $100 Million Registered Direct Offering of Common Stock
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsTM), today announced that it has entered into definitive agreements with . . .
Posted on 2/4/21
Prestige Consumer Healthcare Reports Fiscal 2021 Third Quarter Results
TARRYTOWN, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended . . .
Posted on 2/4/21
Is It Too Late to Buy Pfizer Stock?
Anyone not following the market would probably think that Pfizer (NYSE:PFE) did well last year. With the publicity from a potentially pandemic-ending vaccine and agreements for . . .
Posted on 2/3/21
Valera Health Closes $3.8M Round Led by AXA Venture Partners
Valera Health, a tele-behavioral health service that provides personalized team-based clinical care, announced the closing of a $3.8M round led by AXA Venture Partners
Posted on 2/3/21
NanoVibronix Regains Nasdaq Compliance
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced . . .
Posted on 2/3/21
Why Pfizer's Q4 Results Simply Don't Matter Very Much
Pfizer (NYSE:PFE) achieved several huge milestones in the fourth quarter of 2020. The big drugmaker, along with its German partner BioNTech, reported outstanding data from a . . .
Posted on 2/3/21
Outlook Therapeutics Closes of $35.0 Million Public Offering of Common Stock
MONMOUTH JUNCTION, N.J., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg . . .
Posted on 2/3/21
Hoth Therapeutics Provides Operational Update on Novel Therapeutic Pipeline
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company today is providing shareholders with an update on its pipeline of novel therapeutics targeting dermatological, COVID-19 and support . . .
Posted on 2/2/21
CooperSurgical Acquires AEGEA Medical
CooperSurgical announced today the acquisition of California-based, AEGEA Medical and its FDA-approved Mara Water Vapor Ablation System. The acquisition
Posted on 2/2/21
MetLife Named a ‘Best Place to Work for LGBTQ Equality’
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received a perfect score on the Human Rights Campaign’s Corporate Equality Index (CEI) for the . . .
Posted on 2/2/21
Protara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and . . .
Posted on 2/2/21
Capital Rx Closes $50 Million Series in B
Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., announced today that it has raised $50 million in Series B financing.
Posted on 2/1/21
Quest Diagnostics Named One of 2021 "World's Most Admired Companies" by FORTUNE Magazine for Seventh Consecutive Year
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired . . .
Posted on 2/1/21
Leisure Acquisition Corp. Merge With Ensysce Biosciences
Leisure Acquisition Corp.(NASDAQ: LACQ, LACQU, LACQW), a special purpose acquisition company formed for the purpose of effecting a merger, acquisition or similar business combination, announced today . . .
Posted on 2/1/21
MetLife Named to World’s Most Admired Companies List by Fortune Magazine
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has been named to Fortune magazine’s 2021 list of the “World’s Most Admired Companies.” Eight life . . .
Posted on 2/1/21
SWORD Health Raises $25 Million in Series B
SWORD Health, the world’s fastest growing virtual musculoskeletal (MSK) care provider, has raised a $25 million financing round, bringing SWORD’s cumulative fundraising to $50 million.
Posted on 2/1/21
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., Feb. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company . . .
Posted on 2/1/21
Look Out, Pfizer and Moderna: Here Comes Novavax
Over the last couple of months, COVID-19 vaccines developed by Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) along with its partner BioNTech (NASDAQ:BNTX) have been at the center . . .
Posted on 2/1/21
Better Coronavirus Stock: Johnson & Johnson vs. Pfizer
Pharmaceutical companies Pfizer (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) are two of the biggest players in the race to vaccinate the world against COVID-19. Pfizer's vaccine, . . .
Posted on 2/1/21
Can Moderna and Pfizer Meet President Biden's Vaccine Goals?
If the goal of President Joe Biden is met, at least 100 million doses of vaccine will be delivered into people's arms by his 100th day . . .
New York
